The correct way to take Tepotinib and suggestions for use
Tepotinib (Tepotinib) is a targeted treatment drug for MET gene abnormalities. It is mainly used to treat patients with METNSCLC) with an>exon14 skipping mutation. Tepotinib is usually taken orally in tablet form, and the recommended dose is 450 mg once daily. Patients should take it at the same time every day to maintain stable drug concentrations in the body and achieve optimal therapeutic effects.
When taking tepotinib, patients can choose to take it before or after a meal, but to reduce gastrointestinal discomfort, it is usually recommended to take it with a meal. When taking the medicine, swallow the tablet whole and do not break, chew or dissolve the tablet to ensure normal release and absorption of the medicine in the body. If the patient accidentally misses a dose, he should take it as soon as possible on the same day. However, if it is close to the next dose time, he should skip the missed dose and continue taking it according to the original plan. Never take twice the dose at one time.
While using tepotinib, patients need to pay close attention to their health status and undergo regular medical examinations, including monitoring of liver function, kidney function, and blood oxygen levels. Because tepotinib may cause side effects such as edema, nausea, diarrhea, fatigue, and in severe cases, interstitial lung disease, you should inform your doctor immediately if you experience symptoms such as persistent discomfort or difficulty breathing. Depending on the severity of specific side effects, your doctor may recommend adjusting the dose, interrupting or stopping treatment.
Generally speaking, as an oral targeted drug, tepotinib is relatively convenient to use, but you need to strictly follow the doctor's instructions during the medication, maintain good medication habits, and pay attention to physical changes. Patients should avoid changing the dosage or discontinuing medication on their own, and maintain regular communication with their attending physician to ensure the continuity and safety of treatment and maximize treatment effects.
Reference materials:https://www.tepotinib.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)